<p>Should <em>CYP2C19</em> Genotyping Be Recommended as a Straight Forward Approach to Optimize Clopidogrel Utilization in Patients with Ischemic Stroke Complicated by Type 2 Diabetes Mellitus?</p>-Reference-Cited by-同舟云学术

Should CYP2C19 Genotyping Be Recommended as a Straight Forward Approach to Optimize Clopidogrel Utilization in Patients with Ischemic Stroke Complicated by Type 2 Diabetes Mellitus?

Published:2020-11 Issue: Volume:Volume 13 Page:645-653
ISSN:1178-7066
Container-title:Pharmacogenomics and Personalized Medicine
language:en
Short-container-title:PGPM

Author:

Sun Jialin,Leng Ping,Sun Chen,Xu Wen,Zhao Zhenhuan,Li Xiao,Zhang Xiaolei,Li Jing

Publisher

Informa UK Limited

Subject

Pharmacology,Molecular Medicine

Reference34 articles.

1. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

2. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86. doi:10.1136/bmj.324.7329.71

4. Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction

5. Ticagrelor Versus Clopidogrel as Part of Dual or Triple Antithrombotic Therapy: a Systematic Review and Meta-Analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigating effect of clopidogrel and systematic management on adverse events after interventional therapy for coronary heart disease;Tropical Journal of Pharmaceutical Research;2022-04-28